Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 799 entries
Sorted by: Best Match Show Resources per page
[On childbirth and child rearing. 9. The pregnant woman and her diet].

Josanpu zasshi = The Japanese journal for midwife

Miyasato K, Sakakura K, Suganuma H, Kamata H, Suemitsu H.
PMID: 3854880
Josanpu Zasshi. 1985 Dec;39(12):1065-8.

No abstract available.

Cite
Miyasato K, Sakakura K, Suganuma H, et al. [On childbirth and child rearing. 9. The pregnant woman and her diet]. Josanpu Zasshi. 1985;39(12):1065-8
Miyasato, K., Sakakura, K., Suganuma, H., Kamata, H., & Suemitsu, H. (1985). [On childbirth and child rearing. 9. The pregnant woman and her diet]. Josanpu zasshi = The Japanese journal for midwife, 39(12), 1065-8.
Miyasato, K, et al. "[On childbirth and child rearing. 9. The pregnant woman and her diet]." Josanpu zasshi = The Japanese journal for midwife vol. 39,12 (1985): 1065-8.
Miyasato K, Sakakura K, Suganuma H, Kamata H, Suemitsu H. [On childbirth and child rearing. 9. The pregnant woman and her diet]. Josanpu Zasshi. 1985 Dec;39(12):1065-8. Japanese. PMID: 3854880.
Copy Download .nbib Format: NLM
Abdominal migraine reviewed from both central and peripheral aspects.

World journal of experimental medicine

Kakisaka Y, Uematsu M, Wang ZI, Haginoya K.
PMID: 24520537
World J Exp Med. 2012 Aug 20;2(4):75-7. doi: 10.5493/wjem.v2.i4.75. eCollection 2012 Aug 20.

Despite the 2%-5% prevalence of abdominal migraine (AM) during childhood, the precise mechanism remains unknown. In this review, we present recent studies on AM and speculate its mechanism from both peripheral and central nervous system aspects. Although the main...

Cite
Kakisaka Y, Uematsu M, Wang ZI, et al. Abdominal migraine reviewed from both central and peripheral aspects. World J Exp Med. 2012;2(4):75-7doi: 10.5493/wjem.v2.i4.75.
Kakisaka, Y., Uematsu, M., Wang, Z. I., & Haginoya, K. (2012). Abdominal migraine reviewed from both central and peripheral aspects. World journal of experimental medicine, 2(4), 75-7. https://doi.org/10.5493/wjem.v2.i4.75
Kakisaka, Yosuke, et al. "Abdominal migraine reviewed from both central and peripheral aspects." World journal of experimental medicine vol. 2,4 (2012): 75-7. doi: https://doi.org/10.5493/wjem.v2.i4.75
Kakisaka Y, Uematsu M, Wang ZI, Haginoya K. Abdominal migraine reviewed from both central and peripheral aspects. World J Exp Med. 2012 Aug 20;2(4):75-7. doi: 10.5493/wjem.v2.i4.75. eCollection 2012 Aug 20. PMID: 24520537; PMCID: PMC3905592.
Copy Download .nbib Format: NLM
Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C.

Hepatology research : the official journal of the Japan Society of Hepatology

Tsunoda T, Inui A, Kawamoto M, Sogo T, Komatsu H, Fujisawa T.
PMID: 23607340
Hepatol Res. 2014 Mar;44(3):251-8. doi: 10.1111/hepr.12118. Epub 2013 Apr 24.

AIM: The relationship between pegylated interferon (PEG IFN)-α-2a and growth of children with chronic hepatitis C (CHC) remains unclear. This study was to evaluate the effects of PEG IFN-α-2a on growth.METHODS: From 2003-2012, we prospectively analyzed the data of...

Cite
Tsunoda T, Inui A, Kawamoto M, et al. Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C. Hepatol Res. 2013;44(3):251-8doi: 10.1111/hepr.12118.
Tsunoda, T., Inui, A., Kawamoto, M., Sogo, T., Komatsu, H., & Fujisawa, T. (2014). Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C. Hepatology research : the official journal of the Japan Society of Hepatology, 44(3), 251-8. https://doi.org/10.1111/hepr.12118
Tsunoda, Tomoyuki, et al. "Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C." Hepatology research : the official journal of the Japan Society of Hepatology vol. 44,3 (2014): 251-8. doi: https://doi.org/10.1111/hepr.12118
Tsunoda T, Inui A, Kawamoto M, Sogo T, Komatsu H, Fujisawa T. Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C. Hepatol Res. 2014 Mar;44(3):251-8. doi: 10.1111/hepr.12118. Epub 2013 Apr 24. PMID: 23607340.
Copy Download .nbib Format: NLM
The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber.

Journal of drug assessment

Hashiguchi K, Okubo K, Wakabayashi K, Tanaka N, Watada Y, Suematsu K, Gotoh M.
PMID: 27536427
J Drug Assess. 2012 Oct 09;1(1):40-7. doi: 10.3109/21556660.2012.728547. eCollection 2012.

OBJECTIVE: The study objective was to investigate the prophylactic efficacy of montelukast (MLK) 10 mg in suppressing seasonal allergic rhinitis (SAR) symptoms induced by Japanese cedar (JC) pollen and to determine how many days before exposure to JC in...

Cite
Hashiguchi K, Okubo K, Wakabayashi K, et al. The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber. J Drug Assess. 2012;1(1):40-7doi: 10.3109/21556660.2012.728547.
Hashiguchi, K., Okubo, K., Wakabayashi, K., Tanaka, N., Watada, Y., Suematsu, K., & Gotoh, M. (2012). The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber. Journal of drug assessment, 1(1), 40-7. https://doi.org/10.3109/21556660.2012.728547
Hashiguchi, Kazuhiro, et al. "The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber." Journal of drug assessment vol. 1,1 (2012): 40-7. doi: https://doi.org/10.3109/21556660.2012.728547
Hashiguchi K, Okubo K, Wakabayashi K, Tanaka N, Watada Y, Suematsu K, Gotoh M. The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber. J Drug Assess. 2012 Oct 09;1(1):40-7. doi: 10.3109/21556660.2012.728547. eCollection 2012. PMID: 27536427; PMCID: PMC4980728.
Copy Download .nbib Format: NLM
DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant.

Vaccines

Nyström S, Bråve A, Falkeborn T, Devito C, Rissiek B, Johansson DX, Schröder U, Uematsu S, Akira S, Hinkula J, Applequist SE.
PMID: 26344341
Vaccines (Basel). 2013 Sep 25;1(4):415-43. doi: 10.3390/vaccines1040415.

Eliciting effective immune responses using non-living/replicating DNA vaccines is a significant challenge. We have previously shown that ballistic dermal plasmid DNA-encoded flagellin (FliC) promotes humoral as well as cellular immunity to co-delivered antigens. Here, we observe that a plasmid...

Cite
Nyström S, Bråve A, Falkeborn T, et al. DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant. Vaccines (Basel). 2013;1(4):415-43doi: 10.3390/vaccines1040415.
Nyström, S., Bråve, A., Falkeborn, T., Devito, C., Rissiek, B., Johansson, D. X., Schröder, U., Uematsu, S., Akira, S., Hinkula, J., & Applequist, S. E. (2013). DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant. Vaccines, 1(4), 415-43. https://doi.org/10.3390/vaccines1040415
Nyström, Sanna, et al. "DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant." Vaccines vol. 1,4 (2013): 415-43. doi: https://doi.org/10.3390/vaccines1040415
Nyström S, Bråve A, Falkeborn T, Devito C, Rissiek B, Johansson DX, Schröder U, Uematsu S, Akira S, Hinkula J, Applequist SE. DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant. Vaccines (Basel). 2013 Sep 25;1(4):415-43. doi: 10.3390/vaccines1040415. PMID: 26344341; PMCID: PMC4494208.
Copy Download .nbib Format: NLM
Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits.

Oncotarget

Yoshida T, Ri M, Kanamori T, Aoki S, Ashour R, Kinoshita S, Narita T, Totani H, Masaki A, Ito A, Kusumoto S, Ishida T, Komatsu H, Kitahata S, Chiba T, Ichikawa S, Iida S.
PMID: 29515784
Oncotarget. 2018 Jan 11;9(11):9975-9991. doi: 10.18632/oncotarget.24160. eCollection 2018 Feb 09.

Proteasome inhibitors (PI), mainly targeting the β5 subunit of the 20S proteasome, are widely used in the treatment of multiple myeloma (MM). However, PI resistance remains an unresolved problem in the therapy of relapsed and refractory MM. To develop...

Cite
Yoshida T, Ri M, Kanamori T, et al. Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits. Oncotarget. 2018;9(11):9975-9991doi: 10.18632/oncotarget.24160.
Yoshida, T., Ri, M., Kanamori, T., Aoki, S., Ashour, R., Kinoshita, S., Narita, T., Totani, H., Masaki, A., Ito, A., Kusumoto, S., Ishida, T., Komatsu, H., Kitahata, S., Chiba, T., Ichikawa, S., & Iida, S. (2018). Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits. Oncotarget, 9(11), 9975-9991. https://doi.org/10.18632/oncotarget.24160
Yoshida, Takashi, et al. "Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits." Oncotarget vol. 9,11 (2018): 9975-9991. doi: https://doi.org/10.18632/oncotarget.24160
Yoshida T, Ri M, Kanamori T, Aoki S, Ashour R, Kinoshita S, Narita T, Totani H, Masaki A, Ito A, Kusumoto S, Ishida T, Komatsu H, Kitahata S, Chiba T, Ichikawa S, Iida S. Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits. Oncotarget. 2018 Jan 11;9(11):9975-9991. doi: 10.18632/oncotarget.24160. eCollection 2018 Feb 09. PMID: 29515784; PMCID: PMC5839415.
Copy Download .nbib Format: NLM
High time to study aortic stenosis in the Japanese.

Journal of cardiology

Uematsu M.
PMID: 25892671
J Cardiol. 2015 May;65(5):351-2. doi: 10.1016/j.jjcc.2015.03.001. Epub 2015 Apr 17.

No abstract available.

Cite
Uematsu M. High time to study aortic stenosis in the Japanese. J Cardiol. 2015;65(5):351-2doi: 10.1016/j.jjcc.2015.03.001.
Uematsu, M. (2015). High time to study aortic stenosis in the Japanese. Journal of cardiology, 65(5), 351-2. https://doi.org/10.1016/j.jjcc.2015.03.001
Uematsu, Masaaki. "High time to study aortic stenosis in the Japanese." Journal of cardiology vol. 65,5 (2015): 351-2. doi: https://doi.org/10.1016/j.jjcc.2015.03.001
Uematsu M. High time to study aortic stenosis in the Japanese. J Cardiol. 2015 May;65(5):351-2. doi: 10.1016/j.jjcc.2015.03.001. Epub 2015 Apr 17. PMID: 25892671.
Copy Download .nbib Format: NLM
Anatomical similarity of abdominal aortic aneurysms in monozygotic twins.

Annals of vascular diseases

Kitagawa A, Komatsu H, Nagao T.
PMID: 24995069
Ann Vasc Dis. 2014;7(2):187-90. doi: 10.3400/avd.cr.14-00034. Epub 2014 May 16.

We report the anatomical similarity of abdominal aortic aneurysms (AAAs) regarding morphology and visceral vessel relations with three-dimensional computed tomography in monozygotic twins, both of whom had the left accessory renal artery, patent inferior mesenteric artery and bilateral common...

Cite
Kitagawa A, Komatsu H, Nagao T. Anatomical similarity of abdominal aortic aneurysms in monozygotic twins. Ann Vasc Dis. 2014;7(2):187-90doi: 10.3400/avd.cr.14-00034.
Kitagawa, A., Komatsu, H., & Nagao, T. (2014). Anatomical similarity of abdominal aortic aneurysms in monozygotic twins. Annals of vascular diseases, 7(2), 187-90. https://doi.org/10.3400/avd.cr.14-00034
Kitagawa, Atsushi, et al. "Anatomical similarity of abdominal aortic aneurysms in monozygotic twins." Annals of vascular diseases vol. 7,2 (2014): 187-90. doi: https://doi.org/10.3400/avd.cr.14-00034
Kitagawa A, Komatsu H, Nagao T. Anatomical similarity of abdominal aortic aneurysms in monozygotic twins. Ann Vasc Dis. 2014;7(2):187-90. doi: 10.3400/avd.cr.14-00034. Epub 2014 May 16. PMID: 24995069; PMCID: PMC4072873.
Copy Download .nbib Format: NLM
Phase transition kinetics of LiNi0.5Mn1.5O4 analyzed by temperature-controlled operando X-ray absorption spectroscopy.

Physical chemistry chemical physics : PCCP

Takahashi I, Arai H, Murayama H, Sato K, Komatsu H, Tanida H, Koyama Y, Uchimoto Y, Ogumi Z.
PMID: 26686382
Phys Chem Chem Phys. 2016 Jan 21;18(3):1897-904. doi: 10.1039/c5cp05535k. Epub 2015 Dec 21.

LiNi0.5Mn1.5O4 (LNMO) is a promising positive electrode material for lithium ion batteries because it shows a high potential of 4.7 V vs. Li/Li(+). Its charge-discharge reaction includes two consecutive phase transitions between LiNi0.5Mn1.5O4 (Li1) ↔ Li0.5Ni0.5Mn1.5O4 (Li0.5) and Li0.5...

Cite
Takahashi I, Arai H, Murayama H, et al. Phase transition kinetics of LiNi0.5Mn1.5O4 analyzed by temperature-controlled operando X-ray absorption spectroscopy. Phys Chem Chem Phys. 2015;18(3):1897-904doi: 10.1039/c5cp05535k.
Takahashi, I., Arai, H., Murayama, H., Sato, K., Komatsu, H., Tanida, H., Koyama, Y., Uchimoto, Y., & Ogumi, Z. (2016). Phase transition kinetics of LiNi0.5Mn1.5O4 analyzed by temperature-controlled operando X-ray absorption spectroscopy. Physical chemistry chemical physics : PCCP, 18(3), 1897-904. https://doi.org/10.1039/c5cp05535k
Takahashi, Ikuma, et al. "Phase transition kinetics of LiNi0.5Mn1.5O4 analyzed by temperature-controlled operando X-ray absorption spectroscopy." Physical chemistry chemical physics : PCCP vol. 18,3 (2016): 1897-904. doi: https://doi.org/10.1039/c5cp05535k
Takahashi I, Arai H, Murayama H, Sato K, Komatsu H, Tanida H, Koyama Y, Uchimoto Y, Ogumi Z. Phase transition kinetics of LiNi0.5Mn1.5O4 analyzed by temperature-controlled operando X-ray absorption spectroscopy. Phys Chem Chem Phys. 2016 Jan 21;18(3):1897-904. doi: 10.1039/c5cp05535k. Epub 2015 Dec 21. PMID: 26686382.
Copy Download .nbib Format: NLM
Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients.

World journal of hepatology

Tarao K, Tanaka K, Nozaki A, Sato A, Ishii T, Komatsu H, Ikeda T, Komatsu T, Matsushima S, Oshige K.
PMID: 28469810
World J Hepatol. 2017 Apr 18;9(11):544-550. doi: 10.4254/wjh.v9.i11.544.

AIM: To survey the efficacy and safety of dual therapy with daclatasvir and asunaprevir in the elderly hepatitis C virus (HCV) patients multicentricity.METHODS: Interferon-ineligible/intolerant patients and non-responders to previous pegylated-interferon/ribavirin therapy with chronic HCV genotype 1b infection were enrolled....

Cite
Tarao K, Tanaka K, Nozaki A, et al. Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients. World J Hepatol. 2017;9(11):544-550doi: 10.4254/wjh.v9.i11.544.
Tarao, K., Tanaka, K., Nozaki, A., Sato, A., Ishii, T., Komatsu, H., Ikeda, T., Komatsu, T., Matsushima, S., & Oshige, K. (2017). Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients. World journal of hepatology, 9(11), 544-550. https://doi.org/10.4254/wjh.v9.i11.544
Tarao, Kazuo, et al. "Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients." World journal of hepatology vol. 9,11 (2017): 544-550. doi: https://doi.org/10.4254/wjh.v9.i11.544
Tarao K, Tanaka K, Nozaki A, Sato A, Ishii T, Komatsu H, Ikeda T, Komatsu T, Matsushima S, Oshige K. Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients. World J Hepatol. 2017 Apr 18;9(11):544-550. doi: 10.4254/wjh.v9.i11.544. PMID: 28469810; PMCID: PMC5395803.
Copy Download .nbib Format: NLM
Chronic hepatitis B in children in the United States and Canada: international origins place the disease burden on children even in the era of universal vaccination.

Translational pediatrics

Komatsu H, Inui A.
PMID: 26835398
Transl Pediatr. 2016 Jan;5(1):1-4. doi: 10.3978/j.issn.2224-4336.2015.12.08.

No abstract available.

Cite
Komatsu H, Inui A. Chronic hepatitis B in children in the United States and Canada: international origins place the disease burden on children even in the era of universal vaccination. Transl Pediatr. 2016;5(1):1-4doi: 10.3978/j.issn.2224-4336.2015.12.08.
Komatsu, H., & Inui, A. (2016). Chronic hepatitis B in children in the United States and Canada: international origins place the disease burden on children even in the era of universal vaccination. Translational pediatrics, 5(1), 1-4. https://doi.org/10.3978/j.issn.2224-4336.2015.12.08
Komatsu, Haruki, and Inui, Ayano. "Chronic hepatitis B in children in the United States and Canada: international origins place the disease burden on children even in the era of universal vaccination." Translational pediatrics vol. 5,1 (2016): 1-4. doi: https://doi.org/10.3978/j.issn.2224-4336.2015.12.08
Komatsu H, Inui A. Chronic hepatitis B in children in the United States and Canada: international origins place the disease burden on children even in the era of universal vaccination. Transl Pediatr. 2016 Jan;5(1):1-4. doi: 10.3978/j.issn.2224-4336.2015.12.08. PMID: 26835398; PMCID: PMC4729037.
Copy Download .nbib Format: NLM
Correction: LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C.

PloS one

Masuda K, Chiyoda T, Sugiyama N, Segura-Cabrera A, Kabe Y, Ueki A, Banno K, Suematsu M, Aoki D, Ishihama Y, Saya H, Kuninaka S.
PMID: 25860571
PLoS One. 2015 Apr 10;10(4):e0125308. doi: 10.1371/journal.pone.0125308. eCollection 2015.

No abstract available.

Cite
Masuda K, Chiyoda T, Sugiyama N, et al. Correction: LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C. PLoS One. 2015;10(4):e0125308doi: 10.1371/journal.pone.0125308.
Masuda, K., Chiyoda, T., Sugiyama, N., Segura-Cabrera, A., Kabe, Y., Ueki, A., Banno, K., Suematsu, M., Aoki, D., Ishihama, Y., Saya, H., & Kuninaka, S. (2015). Correction: LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C. PloS one, 10(4), e0125308. https://doi.org/10.1371/journal.pone.0125308
Masuda, Kenta, et al. "Correction: LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C." PloS one vol. 10,4 (2015): e0125308. doi: https://doi.org/10.1371/journal.pone.0125308
Masuda K, Chiyoda T, Sugiyama N, Segura-Cabrera A, Kabe Y, Ueki A, Banno K, Suematsu M, Aoki D, Ishihama Y, Saya H, Kuninaka S. Correction: LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C. PLoS One. 2015 Apr 10;10(4):e0125308. doi: 10.1371/journal.pone.0125308. eCollection 2015. PMID: 25860571; PMCID: PMC4393140.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 799 entries